PLSE
Pulse Biosciences, Inc Common Stock (DE)stockNASDAQ
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 52.25 | 2026-11-12 | -12.32% | 4.784 |
| 1M | 47.55 | 2026-10-19 | -3.65% | 2.581 |
| 3M | 47.02 | 2026-08-19 | -2.56% | 2.185 |
| 6M | 24.95 | 2026-05-19 | +83.63% | 1.897 |
| 1Y | 13.01 | 2025-11-19 | +252.15% | 2.202 |
| 2Y | 17.04 | 2024-11-19 | +168.87% | — |
| 5Y | 21.31 | 2021-11-19 | +114.99% | 1.440 |
Pulse Biosciences, Inc Common Stock (DE) (NASDAQ:PLSE) stock price today is $45.82, and today's volume is 332,035. PLSE is up 2.174% today. The 30 day average volume is 409,076. PLSE market cap is $3.37B with 73.55M shares outstanding.